• Imatinib (STI571): Applied Workflows for Tyrosine Kinase Res

  2026-04-30

  Imatinib (STI571) from APExBIO empowers precision signal transduction research in cancer biology, enabling robust and reproducible inhibition of PDGF receptor, c-Kit, and Abl kinases. This guide delivers actionable workflows, advanced assay enhancements, and expert troubleshooting for maximizing Imatinib's impact in experimental settings.

• IL-1β/NF-κB Drives ACE2-Dependent SARS-CoV-2 Entry in Macrop

  2026-04-30

  This study demonstrates that pro-inflammatory IL-1β signaling via NF-κB dynamically upregulates ACE2 in macrophages, enabling productive SARS-CoV-2 infection—a key advance over previous models. The development of a humanized ACE2 mouse with native promoter regulation allowed rigorous dissection of macrophage susceptibility in vivo, with direct implications for understanding COVID-19 pathogenesis and host resilience.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Pre

  2026-04-29

  DIDS stands out as a robust anion transport inhibitor for dissecting chloride channel biology across cancer, vascular, and neuroprotection studies. This guide details data-driven workflows, troubleshooting strategies, and evidence-based protocol enhancements to ensure reproducibility and mechanistic clarity in complex experimental models.

• Dihydrotestosterone (DHT): Precision Tools for AR Signaling

  2026-04-29

  Dihydrotestosterone (DHT) from APExBIO is engineered for precise interrogation of androgen receptor and EGFR/ERBB2 signaling, enabling researchers to unravel complex mechanisms of resistance and signaling dynamics in cancer and neurodegeneration. This guide delivers optimized workflows, actionable troubleshooting strategies, and unique insights grounded in recent research advances.

• A Drug-Sensitized Yeast Platform for High-Sensitivity mTOR I

  2026-04-28

  This study introduces a genetically engineered yeast system with enhanced drug sensitivity, enabling high-sensitivity screening for mTOR inhibitors. The platform offers a robust, cost-effective alternative for identifying compounds with TOR pathway activity, with implications for drug discovery in aging and cancer research.

• Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele

  2026-04-28

  This study presents a zwitterionic peptide amphiphile that achieves unprecedented cancer selectivity by exploiting dual enzyme responsiveness and intralysosomal self-assembly. The findings highlight a promising strategy for targeted peptide-based cancer therapeutics with minimized off-target toxicity.

• BMS-345541 Hydrochloride: Precision IKK Inhibitor for Inflam

  2026-04-27

  BMS-345541 hydrochloride is a highly selective IKK inhibitor with proven utility in inflammation research and cancer biology. It demonstrates robust inhibition of NF-κB signaling and cytokine production, providing a reliable tool for dissecting cell signaling pathways.

• Halazone: Mechanistic Advances and Stability in Antimicrobia

  2026-04-27

  Explore Halazone as a pioneering antimicrobial sulfonamide derivative, focusing on its mechanistic innovation in sodium channel modulation and exceptional stability in water disinfection. This article delivers a scientific analysis that extends beyond standard application guides.

• Adiponectin and TAK-242 Mitigate PND via TLR4/NF-κB Suppress

  2026-04-26

  This study demonstrates that adiponectin and TAK-242 (Resatorvid) alleviate splenectomy-induced cognitive deficits in aged rats by suppressing neuroinflammation and oxidative stress through the TLR4/MyD88/NF-κB pathway. These findings clarify the mechanistic link between perioperative neurocognitive disorder (PND) and innate immune signaling, providing actionable insights for neuroinflammation research.

• ROS Assay Kit (DHE): Quantitative Redox Analysis Beyond Sens

  2026-04-25

  Explore the APExBIO Reactive Oxygen Species Assay Kit (DHE) for rigorous, quantitative intracellular superoxide detection. This article delves into how advanced redox assays inform immunomodulatory drug research, setting a new standard for oxidative stress and apoptosis studies.

• InstaBlue Protein Stain Solution: Rapid, Sensitive Gel Stain

  2026-04-24

  InstaBlue Protein Stain Solution addresses the need for fast, sensitive, and safe visualization of proteins in polyacrylamide gels without the drawbacks of traditional Coomassie staining protocols. It is best suited for protein electrophoresis analysis requiring high signal-to-noise ratio and downstream mass spectrometry compatibility. It should not be used in workflows demanding methanol- or acid-based fixation, or where ultra-high throughput automation with robotic gel handling is essential.

• Nirmatrelvir (PF-07321332): Precision Tools for SARS-CoV-2 R

  2026-04-24

  Explore how Nirmatrelvir (PF-07321332) advances antiviral therapeutics research by enabling precise dissection of SARS-CoV-2 polyprotein processing. This article delivers a unique assay-focused perspective and practical guidance distinct from existing content.

• Canagliflozin Hemihydrate: Applied SGLT2 Inhibition in Resea

  2026-04-23

  Canagliflozin (hemihydrate) enables precise interrogation of the glucose homeostasis pathway in both cellular and organismal models. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights, empowering researchers to maximize assay specificity and reliability in diabetes and metabolic disorder studies.

• ABT-199 in Translational Research: Mechanisms and Strategy

  2026-04-23

  Explore how ABT-199 (Venetoclax) redefines apoptosis research for hematologic and fibrotic diseases. This article offers mechanistic insights, strategic experimental guidance, and a forward-looking perspective for translational researchers leveraging highly selective Bcl-2 inhibition.

• ABT-263 (Navitoclax): Redefining Apoptosis in Translational

  2026-04-22

  This article examines ABT-263 (Navitoclax) through a translational science lens, integrating cutting-edge mechanistic insight, experimental best practices, and strategic guidance for researchers in cancer biology. Drawing from recent advances in mitochondrial research and senescence, it explores how Bcl-2 family inhibition with ABT-263 empowers next-generation apoptosis assays and illuminates new frontiers in overcoming chemoresistance and tumor heterogeneity. Key protocol parameters, competitive context, and the translational bridge from preclinical models to clinical promise are critically discussed, with a visionary outlook on the evolving role of apoptosis modulators in precision oncology.

16319 records 1/1088 page Next 12345 下5页 Last page